Stocks · Health care · Pharmaceutical Preparations

Liquidia Corp

LQDA Clue Score52
United States Fiscal year ends December CIK 0001819576 Results filed 12 Aug 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Jason Adair
26 Oct 2026
Chief Business Officer
Sold on a plan
688
$43.19
$29.71K
Dana Boyle
26 Oct 2026
Chief Accounting Officer
Sold on a plan
1,581
$43.19
$68.28K
Jason Adair
12 Oct 2026
Chief Business Officer
Sold on a plan
7,301
$28.48
$207.93K
Dana Boyle
12 Oct 2026
Chief Accounting Officer
Sold on a plan
5,892
$28.48
$167.80K
Roger Jeffs
12 Oct 2026
Chief Executive Officer
Sold on a plan
32,744
$28.48
$932.55K
Michael Kaseta
12 Oct 2026
CFO and COO
Sold on a plan
18,938
$28.48
$539.35K
Sanjeev Khindri
12 Oct 2026
Chief Development Officer
Sold on a plan
1,101
$28.48
$31.36K
Sarah Krepp
12 Oct 2026
Chief Human Resource Officer
Sold on a plan
5,245
$28.48
$149.38K
Scott Moomaw
12 Oct 2026
Chief Commercial Officer
Sold on a plan
8,863
$28.48
$252.42K
Rajeev Saggar
12 Oct 2026
Chief Medical Officer
Sold on a plan
9,218
$28.48
$262.53K
Russell Schundler
12 Oct 2026
General Counsel
Sold on a plan
13,692
$28.48
$389.95K

What was left out

Form 4 filings counted 12
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 11
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 83,296
History held since 19 Nov 2020